To ensure delivery to your inbox, please add
newsletter=40vitacost.com
to your address book.
Are you having trouble viewing this email?
See it here
. |
|
|
Sunday, February 15, 2009
|
|
|
|
|
|
|
|
|
|
|
Over 19,000 Health Products
At Your Fingertips=21
|
|
|
|
|
New Test May Help Kidney Transplant Patients
Carolina researchers say it could detect virus that can lead to failure
(HealthDay News) -- A new urine test that can detect a common cause of kidney transplant failure may help lead to better diagnosis and treatment of patients with polyomavirus nephropathy, which affects about 9 percent of kidney transplant patients.
Polyomaviruses are harmless to healthy adults but can cause serious problems for people with compromised immune systems. People having a kidney transplant take medicines to suppress their immune system to protect against organ rejection.
There are no effective treatments for polyomavirus nephropathy, so it's important to diagnose the condition as soon as possible and lower the dose of immunosuppressive drugs in hopes of allowing the immune system to eliminate the virus. Currently, doctors rely on invasive and expensive kidney biopsies to diagnose polyomavirus nephropathy, and these tests sometimes give false negative results.
The new test -- developed by Dr. Volker Nickeleit and colleagues from the University of North Carolina at Chapel Hill -- measures levels of
Haufen,
, a German word for the tightly clustered viral aggregates that form in the kidneys of people with polyomavirus nephropathy and are excreted in the urine.
The researchers said the test takes three hours, costs less than =24400, and is easy to perform with existing laboratory equipment. When the test was used on 160 people, including 21 with early- or late-stage polyomavirus nephropathy, the researchers detected
Haufen
in urine samples from all 21 people with the virus but in none of the 139 study participants without the condition.
The study was published in the February issue of the
Journal of the American Society of Nephrology
.
An early and accurate diagnosis of polyomavirus nephropathy will result in a better understanding of the disease and ultimately improve treatment, Nickeleit said in an American Society of Nephrology news release. Our diagnostic test is unique and could have a tremendous clinical impact.
More information
The National Kidney Foundation has more about
kidney transplant
.
-- Robert Preidt
SOURCE: American Society of Nephrology, news release, Jan. 21, 2009
|
|
|
|
|
I had your company catalog and sat for many hours going over the book and catalog, and I have been ordering the Snygery Ultra, Enzymes, Immunolift and Astragalas for many months now. I was odering many different bottles until I figured I was spending as much on those as the Ultra costs me a month. I am soooo satisified with the products and your company.
|
|
By Penny E. from Montevideo, MN
|
See more customer testimonials
|
|
|
|
|
This is a story from
HealthDay
, a service of ScoutNews, LLC. Copyright =A9 2009
ScoutNews LLC
. All rights reserved.
|
|